Cyndea succesfully finished in July the first US Bioequivalence study for one of the products developed by its R&D department. This is a big milestone in the road of manufacturing for our US customers.
Cyndea is nowadays developing up to 8 ANDAs. The Us market is a strategic territory where we at Cyndea want to focus our efforts.
Recent Posts